Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompass Group Regulatory News (CPG)

Share Price Information for Compass Group (CPG)

Share Price is delayed by 15 minutes
Get Live Data
33.16    0.18 (0.55%)
Bid:
33.15
Ask:
33.17
Spread: 0.02 (0.06%)
Market Cap: $56.38b
CPG Live PriceLast checked at - London Stock Exchange

Intraday Compass Group Share Chart

Share Buyback Programme

12 May 2023 07:00

RNS Number : 1802Z
Compass Group PLC
12 May 2023
 

Legal Entity Identifier (LEI) No. 2138008M6MH9OZ6U2T68

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

SHARE BUYBACK PROGRAMME

 

Further to the half year results announcement made on 10 May 2023, Compass Group PLC (the "Company") announces that the programme to purchase up to £750 million of the Company's ordinary shares of 11 1/20 pence each ("Ordinary Shares") will commence on 12 May 2023 and will be completed this calendar year (the "Programme").

 

The purpose of the Programme is to reduce the share capital of the Company by returning surplus capital to shareholders.

 

The Company has entered into a non-discretionary agreement with J.P. Morgan Securities plc ("JPMS plc") to enable the purchase of up to £250 million of Ordinary Shares for the initial stage of the Programme between 12 May 2023 and 12 July 2023. JPMS plc will make its trading decisions in relation to the Company's Ordinary Shares independently of, and uninfluenced by, the Company. Ordinary Shares acquired by JPMS plc under the Programme will be on-sold by JPMS plc to the Company, with such on-sales to be carried out on the London Stock Exchange.

 

The Programme will be conducted within certain pre-set parameters. The Company's shareholders generally authorised it to purchase up to a maximum of 175,720,000 Ordinary Shares at its 2023 Annual General Meeting held on 9 February 2023, subject to certain limitations (the "General Authority"). The full balance of the General Authority is available to the Company in connection with the Programme, notwithstanding announcements dated 10 February 2023 to 3 April 2023 in connection with purchases of Ordinary Shares by the Company under the share buyback programme announced on 21 November 2022. The aggregate number of Ordinary Shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the General Authority.

 

In addition to compliance with the terms of the General Authority, the Programme will also be conducted within the parameters prescribed by the Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation (EU) 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and in accordance with Chapter 12 of the UK Listing Rules.

 

All Ordinary Shares purchased will be held in treasury and are expected to be used to meet obligations arising from employee share schemes, or other allocations of shares, to employees or directors. No purchases will be made in respect of the Company's American Depositary Receipts.

 

Enquiries

 

Investors:

Agatha Donnelly & Helen Javanshiri

+44 (0) 1932 573 000

Press:

Giles Robinson

+44 (0) 1932 963 486

Website:

www.compass-group.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSABMBTMTJBTAJ
Date   Source Headline
1st Oct 20207:00 amRNSTotal Voting Rights
30th Sep 20207:00 amRNSPre-Close Trading Update
24th Sep 202010:55 amRNSDirectorate Change
1st Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20205:30 pmRNSAnnual Update of Euro Medium Term Note Programme
19th Aug 202010:00 amRNSDirector/PDMR Shareholding
18th Aug 20207:00 amRNSChair Announcement
12th Aug 20204:41 pmRNSSecond Price Monitoring Extn
12th Aug 20204:36 pmRNSPrice Monitoring Extension
11th Aug 202011:00 amRNSDirector Declaration
3rd Aug 20207:00 amRNSTotal Voting Rights
30th Jul 20207:00 amRNSTrading Statement
27th Jul 20204:41 pmRNSSecond Price Monitoring Extn
27th Jul 20204:36 pmRNSPrice Monitoring Extension
8th Jul 202011:00 amRNSHolding(s) in Company
1st Jul 202011:00 amRNSDirector Declaration
1st Jul 20207:00 amRNSTotal Voting Rights
11th Jun 202010:00 amRNSDirector Declaration
8th Jun 20206:22 pmRNSHolding(s) in Company
5th Jun 20203:00 pmRNSDirector/PDMR Shareholding
1st Jun 20203:00 pmRNSDirector/PDMR Shareholding
1st Jun 20207:00 amRNSTotal Voting Rights
20th May 20205:30 pmRNSCompass Group
19th May 20206:20 pmRNSResults of Placing
19th May 20207:01 amRNSRetail Offer via PrimaryBid.com
19th May 20207:00 amRNSLaunch announcement
19th May 20207:00 amRNSUpdate on Covid-19 and Half Year Results
15th May 20205:22 pmRNSResponse to press speculation
15th May 20204:41 pmRNSSecond Price Monitoring Extn
15th May 20204:36 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
27th Apr 20202:30 pmRNSDisclosure of rights attached to equity shares
23rd Apr 20207:00 amRNSCOVID-19 Update
17th Apr 202010:15 amRNSPrice Monitoring Extension
9th Apr 202010:30 amRNSDirector Declaration
1st Apr 202010:00 amRNSBlock listing Interim Review
1st Apr 20207:00 amRNSTotal Voting Rights
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSCoronavirus (COVID-19) Trading Update
13th Mar 20204:36 pmRNSPrice Monitoring Extension
3rd Mar 20206:10 pmRNSDirector/PDMR Shareholding
2nd Mar 20207:00 amRNSTotal Voting Rights
27th Feb 20207:26 amRNSDirector Declaration
26th Feb 20205:40 pmRNSDirector/PDMR Shareholding
26th Feb 20202:50 pmRNSDirector/PDMR Shareholding
7th Feb 202012:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.